Epidemiology, clinical profiles, and prognostic value of COVID‐19‐related cutaneous manifestations in African populations: a rapid narrative review
International Journal of Dermatology · 2024
DOI: 10.1111/ijd.16872 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Peter S Nyasulu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town,…. Hauptthemen laut MEDLINE: COVID-19, Urticaria, Exanthema, Chilblains. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Skin manifestations’ true prognostic value, and clinical and epidemiological pictures in SARS‐CoV‐2 infection in African populations are poorly described and understudied. More familiarity with COVID‐19 cutaneous manifestations may aid in early clinical diagnosis or guide prognosis.
Methods
In this literature review, we looked for potential studies published from December 2019 to March 2023 on COVID‐19 cutaneous lesions in African populations. Our key questions were focused on the prognostic values of cutaneous manifestations related to COVID‐19.
Results
Our findings show that cutaneous manifestations of COVID‐19 vary by country and severity of COVID‐19, primarily multisystem inflammatory syndrome (MIS). Significant differences were also found between various dermatological lesions, primarily MIS, erythema multiforme‐like, livedoid, vesicular, or varicella‐like rashes, urticarial, maculopapular or morbilliform rashes, and chilblain‐like or pernio‐like rashes. There were 47.5% (115/242) of MIS cases reported in nine published African studies. Our findings also revealed that MIS may be diagnosed in 2–7 days due to early onset rash. Advanced age, obesity, diabetes, cardiovascular disease, HIV, tuberculosis, asthma, atopic disease, underweight, malnutrition, and malignancy were found to be associated with COVID‐19 cutaneous manifestations in African populations.
Conclusions
COVID‐19‐related skin manifestations in African populations are important as a driving force in COVID‐19 prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
- Division of Epidemiology & Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
ORCID-Profile: Peter S Nyasulu, Jacques L Tamuzi
Zitieren
APA
Nyasulu, P. S., & Tamuzi, J. L. (2024). Epidemiology, clinical profiles, and prognostic value of COVID‐19‐related cutaneous manifestations in African populations: a rapid narrative review. International Journal of Dermatology. https://doi.org/10.1111/ijd.16872
Vancouver
Nyasulu PS, Tamuzi JL. Epidemiology, clinical profiles, and prognostic value of COVID‐19‐related cutaneous manifestations in African populations: a rapid narrative review. International Journal of Dermatology. 2024. doi:10.1111/ijd.16872
BibTeX
@article{Nyasulu2024,
author = {Nyasulu, Peter S and Tamuzi, Jacques L},
title = {Epidemiology, clinical profiles, and prognostic value of COVID‐19‐related cutaneous manifestations in African populations: a rapid narrative review},
journal = {International Journal of Dermatology},
year = {2024},
doi = {10.1111/ijd.16872}
}
EUVIMED